IBEX Ltd
For the period ended Jun 30, 2025. Filed Sep 11, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Sep 11, 2025
IBEX$52.23+3.9%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Stockholders’ Equity
(in thousands)
| Common shares · TreasuryStock · AdditionalPaid-inCapital · Accumulated OtherComprehensiveIncome / (Loss) · Retained Earnings / (Deficit) · TotalStockholders'Equity | |||||||
|---|---|---|---|---|---|---|---|
| Shares · Amount · Amount | |||||||
| Balance, June 30, 2022 | 18,247 | $2 | $(3,406) | $197,785 | $(4,562) | $(76,360) | $113,459 |
| Net income for the period ended June 30, 2023 | — | — | — | — | — | 31,582 | 31,582 |
| Foreign currency translation adjustment | — | — | — | — | (2,234) | — | (2,234) |
| Changes in fair value of cash flow hedges | — | — | — | — | 515 | — | 515 |
| Purchase of treasury shares | (18) | — | (276) | — | — | — | (276) |
| Changes in defined benefit plan | — | — | — | — | (31) | — | (31) |
| Forfeiture of restricted common shares | (72) | — | — | — | — | — | — |
| Provision for common stock warrants | — | — | — | 1,090 | — | — | 1,090 |
| Issue of common shares related to option issuances | 123 | — | — | 2,053 | — | — | 2,053 |
| Stock based compensation expense | — | — | — | 3,806 | — | — | 3,806 |
| Balance, June 30, 2023 | 18,280 | $2 | $(3,682) | $204,734 | $(6,312) | $(44,778) | $149,964 |
| Net income for the period ended June 30, 2024 | — | — | — | — | — | 33,655 | 33,655 |
| Foreign currency translation adjustment | — | — | — | — | (1,623) | — | (1,623) |
| Changes in fair value of cash flow hedges | — | — | — | — | (111) | — | (111) |
| Purchase of treasury shares | (1,322) | — | (21,685) | — | — | — | (21,685) |
| Changes in defined benefit plan | — | — | — | — | 133 | — | 133 |
| Provision for common stock warrants | — | — | — | 1,183 | — | — | 1,183 |
| Issue of common shares related to option issuances | 59 | — | — | 366 | — | — | 366 |
| Stock based compensation expense | — | — | — | 3,917 | — | — | 3,917 |
| Balance, June 30, 2024 | 17,017 | $2 | $(25,367) | $210,200 | $(7,913) | $(11,123) | $165,799 |
| Net income for the period ended June 30, 2025 | — | — | — | — | — | 36,864 | 36,864 |
| Foreign currency translation adjustment | — | — | — | — | 1,114 | — | 1,114 |
| Changes in fair value of cash flow hedges | — | — | — | — | 775 | — | 775 |
| Purchase of treasury shares | (3,948) | (1) | (77,971) | — | — | — | (77,972) |
| Changes in defined benefit plan | — | — | — | — | (312) | — | (312) |
| Issue of common shares related to option issuances | 289 | — | — | 4,307 | — | — | 4,307 |
| Stock based compensation expense | — | — | — | 3,734 | — | — | 3,734 |
| Balance, June 30, 2025 | 13,358 | $1 | $(103,338) | $218,241 | $(6,336) | $25,741 | $134,309 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.